Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 327
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
The Problems We Will Be Lucky to Have
Pα+ Psychedelic Bulletin #234: Psychedelics After the Midterms; FDA Answers House Psychedelics Caucus; ICER to Review Compass’ Psilocybin; Terran v. Compass Gets Trial Date
Is It Worth It? What Colorado’s Early Experience With Regulated Psychedelic Care Has the Field Asking, and What To Do About It
Compass Says NDA Will Be Filed Within Two Weeks, Declines to Comment on Usona
Podcast: Usona Files Psilocybin Application, We Review 610 Comments Submitted to FDA, and FDA Approves NRx’s Generic Ketamine
Field Trip Health Ltd. Announces Official Opening of Psychedelic Research and...
Ayahuasca’s Role in the Entourage Effect and Depression
Psychedelics Show Promise for Treating Dementia
Catching Up with the Psychedelic Entourage Effect: Part 3 – Field...
Insight into Ayahuasca’s Antidepressant Effects
New Toad Venom Compound Synthesized for Clinical Use: 5-MeO-DMT Succinate
‘Pharmacopeia’ Season Finale Features Cutting Edge Psychedelic Research
The Role of Oxytocin in MDMA’s Prosocial Effects
The Ancestral Healing Power of Ayahuasca
Pharmacological Testing in Psychedelic Research
Load more
